Patrick Zweidler-McKay
Company: Sidewinder Therapeutics
Job title: Fractional Chief Medical Officer
Seminars:
Session Chair’s Opening Remarks 7:50 am
day: Day One P1
Investor Icebreaker: When Being Selective, where will Investors Invest? 11:45 am
For both venture and investing out of public funds, what will drive investment in ADCs and what will inhibit it? With the data readouts from ASCO, will your considerations for investment change? How can and will ADCs remain relevant to investors?Read more
day: Day One P2
Considerations for Quality of Life When Assessing Assets Earlier in Development 9:00 am
day: Day One Red Track